RPM CD19-mbIL15-CAR-T cells / Alaunos Therap, UT MD Anderson Cancer Center, Eden BioCell 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
RPM CD19-mbIL15-CAR-T cells / Alaunos Therap, UT MD Anderson Cancer Center, Eden BioCell
ChiCTR2000034793: An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti-CD19 Autologous CAR T-cells Produced by Rapid Personalized Manufacture (RPM CD19-mbIL15-CAR-T Cell Infusion) in Patients With Relapsed/Refractory B-cell Malignancies

Not yet recruiting
N/A
12
 
RPM CD19-mbIL15-CAR-T cell infusion
Ningbo First Hospital; TriArm Therapeutics (Shanghai) Co., Ltd, TriArm Therapeutics (Shanghai) Co., Ltd
B cell malignancy
 
 
ChiCTR2100050678: An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti-CD19 Autologous CAR T-cells Produced by Rapid Personalized Manufacture (RPM CD19-mbIL15-CAR-T Cell Infusion) in Patients With Relapsed/Refractory B-cell Malignancies

Recruiting
N/A
12
 
Treat with RPM CD19-mbIL15-CAR-T cells
Tongji Hospital of Tongji University; TriArm Therapeutics (shanghai) Co., Ltd., TriArm Therapeutics (Shanghai) Co., Ltd
B cell malignancy
 
 

Download Options